Liang Cheng Selected Research

Eosine Yellowish-(YS) (Eosin)

1/2020	Computational analysis of pathological images enables a better diagnosis of TFE3 Xp11.2 translocation renal cell carcinoma.
2/2018	Effects of Tirofiban on Random Skin Flap Survival in Rats.
11/2017	Naringin improves random skin flap survival in rats.
12/2016	Utilization of Cell-Transfer Technique for Molecular Testing on Hematoxylin-Eosin-Stained Sections: A Viable Option for Small Biopsies That Lack Tumor Tissues in Paraffin Block.
2/2016	The utility of CDX2, GATA3, and DOG1 in the diagnosis of testicular neoplasms: an immunohistochemical study of 109 cases.
1/2014	qPCR increases sensitivity to detect cytomegalovirus in formalin-fixed, paraffin-embedded tissue of gastrointestinal biopsies.
9/2010	Interobserver reproducibility in the diagnosis of invasive micropapillary carcinoma of the urinary tract among urologic pathologists.
7/2006	Adrenal myelolipomas show nonrandom X-chromosome inactivation in hematopoietic elements and fat: support for a clonal origin of myelolipomas.
2/2005	Eosinophilic and classic chromophobe renal cell carcinomas have similar frequent losses of multiple chromosomes from among chromosomes 1, 2, 6, 10, and 17, and this pattern of genetic abnormality is not present in renal oncocytoma.
7/2004	OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liang Cheng Research Topics

Disease

527	Neoplasms (Cancer) 05/2024 - 01/2002
138	Prostatic Neoplasms (Prostate Cancer) 12/2023 - 02/2002
104	Carcinoma (Carcinomatosis) 02/2024 - 01/2002
70	Urinary Bladder Neoplasms (Bladder Cancer) 02/2024 - 01/2006
70	Renal Cell Carcinoma (Grawitz Tumor) 12/2023 - 10/2003
56	Adenocarcinoma 12/2022 - 01/2002
54	Neoplasm Metastasis (Metastasis) 04/2024 - 09/2002
30	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 10/2022 - 09/2003
29	Inflammation (Inflammations) 01/2024 - 01/2015
26	Carcinogenesis 01/2022 - 01/2002
25	Infections 01/2022 - 11/2010
22	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 08/2008
21	Prostatic Intraepithelial Neoplasia 01/2016 - 02/2002
17	Wounds and Injuries (Trauma) 02/2024 - 11/2010
17	Hypoxia (Hypoxemia) 12/2023 - 08/2009
17	Margins of Excision 11/2019 - 09/2003
16	Breast Neoplasms (Breast Cancer) 04/2024 - 03/2012
16	Lymphatic Metastasis 01/2022 - 09/2002
13	COVID-19 01/2024 - 10/2020
13	Seminoma 10/2022 - 07/2004
12	Disease Progression 10/2022 - 09/2002
12	Carcinoma in Situ 04/2022 - 02/2004
11	Testicular Neoplasms (Testicular Cancer) 12/2023 - 09/2003
11	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 01/2005
10	Small Cell Carcinoma 10/2020 - 03/2005
10	Circulating Neoplastic Cells 01/2020 - 06/2015
9	Necrosis 01/2023 - 09/2003
9	Teratoma (Teratoid Tumor) 10/2022 - 09/2003
9	Melanoma (Melanoma, Malignant) 10/2022 - 07/2007
8	Lung Neoplasms (Lung Cancer) 01/2022 - 04/2011
8	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2017
8	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 12/2014
8	Kidney Neoplasms (Kidney Cancer) 01/2020 - 02/2005
8	Embryonal Carcinoma 05/2011 - 07/2004

Drug/Important Bio-Agent (IBA)

85	Biomarkers (Surrogate Marker)IBA 02/2024 - 10/2004
67	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2002
37	ParaffinIBA 01/2023 - 01/2002
30	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2002
26	Immune Checkpoint InhibitorsIBA 04/2024 - 10/2017
23	AntibodiesIBA 03/2024 - 07/2004
22	Formaldehyde (Formol)FDA Link 01/2023 - 01/2002
21	Prostate-Specific Antigen (Semenogelase)IBA 05/2020 - 09/2002
20	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2024 - 07/2010
17	Phenobarbital (Luminal)FDA Link 02/2024 - 02/2007
17	Transcription Factors (Transcription Factor)IBA 12/2023 - 08/2004
17	Hormones (Hormone)IBA 01/2023 - 09/2002
17	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2015
16	Long Noncoding RNAIBA 01/2024 - 09/2015
16	RNA (Ribonucleic Acid)IBA 01/2024 - 09/2007
16	Androgen Receptors (Androgen Receptor)IBA 12/2023 - 01/2002
16	Cisplatin (Platino)FDA LinkGeneric 06/2023 - 09/2004
16	AntigensIBA 01/2020 - 09/2002
15	AndrogensIBA 12/2023 - 09/2002
15	1-phenyl-3,3-dimethyltriazene (PDT)IBA 09/2022 - 09/2011
14	MetalsIBA 01/2024 - 03/2014
14	Oxygen (Dioxygen)IBA 01/2023 - 11/2015
14	Coloring Agents (Dyes)IBA 10/2021 - 06/2006
13	Messenger RNA (mRNA)IBA 02/2024 - 01/2006
13	Keratin-7 (Cytokeratin 7)IBA 01/2023 - 08/2006
13	ErbB Receptors (EGF Receptor)IBA 01/2019 - 02/2007
12	Therapeutic UsesIBA 01/2023 - 06/2012
12	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 07/2013
11	CytokinesIBA 01/2024 - 12/2010
11	Peptides (Polypeptides)IBA 12/2023 - 12/2005
11	PolymersIBA 03/2023 - 09/2011
11	CollagenIBA 03/2023 - 07/2006
11	PlatinumIBA 01/2022 - 09/2003
11	LigandsIBA 01/2022 - 01/2006
11	Keratins (Keratin)IBA 01/2021 - 09/2004
11	MicellesIBA 10/2020 - 08/2012
10	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2021 - 07/2004
10	Eosine Yellowish-(YS) (Eosin)IBA 01/2020 - 07/2004
10	Hematoxylin (Haematoxylon)IBA 01/2020 - 07/2004
10	Racemases and Epimerases (Epimerases and Racemases)IBA 01/2019 - 09/2004
9	Glutathione (Reduced Glutathione)IBA 01/2024 - 01/2019
9	EnzymesIBA 01/2022 - 01/2002
9	alpha-methylacyl-CoA racemaseIBA 01/2021 - 02/2007
9	Monoclonal AntibodiesIBA 01/2020 - 09/2002
8	B7-H1 AntigenIBA 04/2024 - 04/2016
8	HydrogelsIBA 02/2024 - 11/2005
8	InterferonsIBA 01/2024 - 12/2012
8	Coenzyme A (CoA)IBA 01/2019 - 09/2004
8	Gemcitabine FDA Link 01/2019 - 11/2010
8	LipidsIBA 10/2017 - 01/2008

Therapy/Procedure

268	Therapeutics 04/2024 - 10/2004
71	Drug Therapy (Chemotherapy) 06/2023 - 09/2003
70	Prostatectomy (Retropubic Prostatectomy) 01/2023 - 07/2002
61	Immunotherapy 05/2024 - 06/2003
61	Precision Medicine 04/2023 - 10/2011
34	Radiotherapy 10/2023 - 09/2004
32	Cystectomy 04/2022 - 01/2002
28	Photothermal Therapy 07/2023 - 06/2012
27	Lasers (Laser) 07/2023 - 09/2003
21	Intravenous Injections 01/2023 - 03/2012
17	Lymph Node Excision (Lymph Node Dissection) 02/2021 - 09/2002
16	Castration 12/2023 - 07/2004
14	Neoadjuvant Therapy 02/2023 - 08/2016
14	Nephrectomy 05/2022 - 10/2005
11	Photochemotherapy (Photodynamic Therapy) 09/2022 - 09/2011
8	Orchiectomy (Orchidectomy) 10/2022 - 05/2004